NCT06689163: A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 66 planned
- Started
- 11 Dec 2024
- Primary completion
- 30 Nov 2025
- Arms
- HRS-1167 combined with abiraterone acetate tablets (II) and prednisone
- Results
- None posted
- 14 Nov 2024: Trial registered
- 11 Dec 2024: Trial started